.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Covington
Queensland Health
UBS
Cantor Fitzgerald
Farmers Insurance
Mallinckrodt
Baxter
Citi

Generated: July 22, 2017

DrugPatentWatch Database Preview

Alcon Pharms Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALCON PHARMS LTD, and when can generic versions of ALCON PHARMS LTD drugs launch?

ALCON PHARMS LTD has fifteen approved drugs.

There is one US patent protecting ALCON PHARMS LTD drugs.

There are eighteen patent family members on ALCON PHARMS LTD drugs in sixteen countries.

Summary for Applicant: Alcon Pharms Ltd

Patents:1
Tradenames:14
Ingredients:14
NDAs:15
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC081043-001Oct 24, 1991DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC089172-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 2000DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062714-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alcon Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 20015,849,792► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 20015,889,052► Subscribe
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 20004,911,920*PED► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 20016,011,062► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 20015,510,383► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ALCON PHARMS LTD drugs

Drugname Dosage Strength Tradename Submissiondate
travoprost
Ophthalmic Solution0.00%
TRAVATAN
11/28/2008

International Patent Family for Alcon Pharms Ltd Drugs

Country Document Number Estimated Expiration
Hong Kong1055251► Subscribe
Germany60141477► Subscribe
Austria459337► Subscribe
South Korea20070087252► Subscribe
Portugal1343474► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Alcon Pharms Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB12/038United Kingdom► SubscribePRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129
/2008Austria► SubscribePRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
0784Netherlands► SubscribePRODUCT NAME: EEN OCULAIRE OPLOSSING WELKE FENYLEFRINE BEVAT, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN, ALSMEDE KETOROLAC, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/15/1018 20150730
C0090France► SubscribePRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Merck
Farmers Insurance
Daiichi Sankyo
McKinsey
Cipla
Julphar
Fish and Richardson
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot